A ready-to-use premixed formulation of Adrenalin ® (epinephrine in 0.9% sodium chloride injection) has been made available by Endo, Inc. Adrenalin is a non-selective alpha and beta adrenergic agonist ...

One approach to earlier administration of epinephrine during OHCA is via the intraosseous route, as this can be performed quickly in the field. In our laboratory, Zuercher et al. recently found that ...

"The first-ever ready-to-use epinephrine premixed bag represents an advancement for both providers and patients thanks to a delivery system that provides greater workflow efficiency, saves time, and ...

Endo's products are the first FDA-approved and currently the only commercially available manufacturer-prepared epinephrine premixed intravenous (IV) bag "Hospital pharmacists and healthcare providers ...

Epinephrine nasal solutions from BPI Labs and Endo USA should not be used, according to the FDA. Similarities between the packaging for certain intranasal and intravenous epinephrine products may ...

Many patients fail to carry or use their autoinjectors because they are afraid of needles. NDS1C epinephrine nasal spray had outcomes comparable with autoinjectors and manual injection. An intranasal ...

To date, no randomized controlled human trial has specifically evaluated early epinephrine administration in cardiac arrest and CPR. While several observational studies have reported on epinephrine ...

MALVERN, Pa., Dec. 2, 2024 /PRNewswire/ -- Endo, Inc. (OTCQX: NDOI) announced today the launch of its ADRENALIN® (epinephrine in 0.9% sodium chloride injection) ready-to-use premixed bag, the first ...